Internal Medicine, Hematology & Oncology · Broomall, PA
NPI
1386057651
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
30 Lawrence Rd Ste 201
Broomall, PA, 19008
Phone (610) 492-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
113,797 services
Medicare patients, 2024
466
Average age 75
Drug cost, 2024
$2.5M
1,709 prescriptions
Company payments, 2025
$3,092
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander P Deak Jr. was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 20,720 times for 23 patients. In total Alexander P Deak Jr. billed 113,797 services in 112 codes, and Medicare paid $1.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 20,720 | 23 | $2.30 | $48K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 9,690 | 12 | $0.28 | $2,694 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 5,800 | 52 | $15.86 | $92K |
| J0897 Injection, denosumab, 1 mg | Office | 4,080 | 14 | $20.30 | $83K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,562 | 89 | $0.09 | $228 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 2,508 | 11 | $21.14 | $53K |
| 85025 Blood Count | Office | 1,057 | 357 | $7.60 | $8,030 |
| 36415 Venipuncture Blood Collection | Office | 858 | 331 | $8.65 | $7,422 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 700 | 20 | $0.73 | $512 |
| 99214 Office E&M - Established | Office | 576 | 275 | $96.57 | $56K |
| 99215 Office E&M - Established | Office | 401 | 119 | $144.45 | $58K |
| 96372 Injection Administration | Office | 225 | 65 | $11.58 | $2,606 |
| 96367 Intravenous Infusion, Hydration | Office | 218 | 84 | $23.09 | $5,034 |
| J3490 Unclassified drugs | Office | 212 | 89 | $0.55 | $117 |
| 96413 Chemotherapy Administration | Office | 171 | 47 | $106.39 | $18K |
By year: 2022 $834K for 78,399 services; 2023 $1.1M for 84,832 services; 2024 $1.7M for 113,797 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,057 | 357 | $7.60 | $8,030 |
| 36415 Venipuncture Blood Collection | 858 | 331 | $8.65 | $7,422 |
Medicare prescription drug claims, 2024
In 2024, the drug Alexander P Deak Jr. prescribed most often to Medicare patients was Omeprazole, with 148 prescriptions and refills. In total Alexander P Deak Jr. wrote 1,709 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 148 | 237 | 43 | $896 |
| Eliquis Apixaban | 134 | 200 | 27 | $114K |
| Famotidine Generic | 109 | 180 | 37 | $613 |
| Dexamethasone Generic | 75 | 86 | 35 | $1,662 |
| Xarelto Rivaroxaban | 51 | 85 | Under 11 | $47K |
| Furosemide Generic | 50 | 60 | 16 | $102 |
| Ondansetron Odt Ondansetron | 43 | 43 | 27 | $618 |
| Hydroxyurea Generic | 39 | 97 | 12 | $1,107 |
| Mirtazapine Generic | 36 | 55 | Under 11 | $760 |
| Bortezomib Generic | 36 | 36 | Under 11 | $8,816 |
| Letrozole Generic | 34 | 88 | Under 11 | $462 |
| Prednisone Generic | 29 | 34 | 15 | $175 |
| Pantoprazole Sodium Generic | 28 | 54 | Under 11 | $421 |
| Tramadol Hcl Generic | 28 | 28 | 20 | $139 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 27 | 27 | Under 11 | $284K |
Brand drugs: 484 claims; generic drugs: 1,225 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander P Deak Jr. $3,092 ($3,092 in general payments such as food, travel and fees) from 33 companies. The largest payer was Shield Therapeutics Inc with $718.
| Company | Payments | Amount |
|---|---|---|
| Shield Therapeutics Inc STX.L | 36 | $718 |
| Pfizer Inc. PFE | 24 | $329 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $286 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $160 |
| Daiichi Sankyo Inc. 4568.T | 5 | $131 |
| Astellas Pharma US Inc 4503.T | 5 | $126 |
| Janssen Biotech, Inc. JNJ | 5 | $111 |
| GlaxoSmithKline, LLC. GSK | 5 | $103 |
| BeOne Medicines USA, Inc. ONC | 4 | $103 |
| Abbvie Inc. ABBV | 5 | $101 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.